-
FDA safety review of abortion pill may extend past midterms, infuriating pro-life bankroller
30 Jan 2026 05:36 GMT
… the outcome of FDA’s review" of the risk evaluation and mitigation strategy around mifepristone … the administration protects "unscrupulous drug dealers" by retaining … in-person dispensing requirements for medication abortion in a national …
-
Trump DOJ seeks stay for Louisiana suit to end mailing of abortion drugs
29 Jan 2026 04:34 GMT
… and Drug Administration policy that allows doctors to prescribe abortion medication without … from anti-abortion groups, FDA Administrator Marty Makary began a … what the agency calls its Risk Evaluation and Mitigation Strategy, or REMS. Reproductive health …
-
FDA Claims Mail-Order Abortion Policies Are Not Preventing States From Protecting The Unborn
29 Jan 2026 01:54 GMT
… a judge suspend the FDA’s current Risk Evaluation and Mitigation Strategy standards for mifepristone. … states like Louisiana, where medication abortions are technically illegal. … President Marjorie Dannenfelser. “Abortion drugs accessible by mail are killing …
-
Indian American researchers find way to reduce risks of adverse effects from expedited FDA drug approval
19 Jan 2026 15:38 GMT
… possible while also upholding the medical oath of ‘Do no harm … Shah manually combed through FDA approvals for 300 drugs approved between 2012 … .
They found that when the “Risk Evaluation and Mitigation Strategies” tool was used, the number …
-
Pro-life organization calls on HHS and FDA to suspend abortion pill approval, tighten safety rules
22 Jan 2026 15:43 GMT
… . and U.S. Food and Drug Administration (FDA) Commissioner Dr. Marty Makary … by mail under its risk evaluation and mitigation strategy (REMS) program. The FDA advises against buying … of mifepristone, the first medication in a medical abortion, at Alamo Women …
-
Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report
20 Jan 2026 15:59 GMT
… significantly bolster Sun Pharma';s presence in … system to Laborie Medical for $465 million as … Food and Drug Administration (FDA) approved a supplemental New Drug Application for … approval includes a new Risk Evaluation and Mitigation Strategy (REMS) program in …
-
<![CDATA[FDA approves 5-year use for etonogestrel implant 68 mg contraceptive]]>
20 Jan 2026 02:10 GMT
… Research and Development and Chief Medical Officer. “The sNDA approval … approval, the FDA is requiring implementation of a new Risk Evaluation and Mitigation Strategy (REMS) … Organon announces US Food and Drug Administration approval of supplemental new …
-
FDA Approves Organon's SNDA Extending NEXPLANON Use To Five Years With New REMS Program
17 Jan 2026 08:17 GMT
… . Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA … were identified.
The FDA approval also includes a new Risk Evaluation and Mitigation Strategy (REMS) program …
-
Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque
17 Jan 2026 04:29 GMT
… distribute to certified pharmacies and certified healthcare providers … or affecting Medicare, Medicaid and health care reform, pharmaceutical pricing … www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems …
-
Senate hearing examines abortion pill after FDA approval of new generic version
15 Jan 2026 03:34 GMT
… particularly outside of medical settings.
“At … suggestions from FDA and Department … pharmacies to prescribe dangerous chemical abortion drugs and to let mail order pharmacies … strengthen the (Risk Evaluation and Mitigation Strategy) program for mifepristone …